Smith & Nephew

Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England.[9] It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products.[8] Its products are sold in over 120 countries.[8] It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

Smith & Nephew plc
Public limited company
Traded asLSE: SN
NYSE: SNN
FTSE 100 Component
ISINGB0009223206 
IndustryMedical equipment
Founded1856 (1856)[1][2][3]
(Kingston upon Hull)
FounderThomas James Smith[4][5][6]
HeadquartersWatford, England, UK
Key people
Revenue$5,138 million (2019)[7]
$815 million (2019)[7]
$600 million (2019)[7]
Number of employees
16,000 (2019)[8]
Websitewww.smith-nephew.com


[10][11][12]

History

The company was founded in 1856 by Thomas James Smith of Kingston upon Hull who went into business as a dispensing chemist.[13] A few months before his death in 1896, Smith was joined by his nephew, Horatio Nelson Smith, and the business became known as T. J. Smith and Nephew.[13]

In 1928 the company acquired the licence to market and produce the Elastoplast range of bandages. By 1977 the company acquired the pump manufacturer Watson-Marlow Pumps, before selling it to Spirax-Sarco Engineering in 1990.[14] In 1986 it went on to acquire Richards Medical Company, a US specialist in orthopaedic products for £201 million.[13]

In 2002 the company acquired Oratec Interventions, a surgical devices business, for $310 million.[15] It went on to buy Midland Medical Technologies, a hip resurfacing business, for £67 million in 2004.[16]

The company acquired Plus Orthopedics, a Swiss orthopedics business, for US$889 million in April 2007[17] and BlueSky, a US wound care business, for $110 million in May 2007.[18]

In September 2007 Biomet Inc., DePuy Orthopaedics Inc. (part of Johnson & Johnson), Smith & Nephew PLC and Zimmer Holdings Inc. entered into settlement agreements, under which they agree to pay $300 million in total, adopt industry overhauls and undertake corporate monitoring to avoid criminal charges of conspiracy.[19]

The company acquired Healthpoint Biotherapeutics, a specialist in the bioactives area of advanced wound management, for $782 million in December 2012.[20]

In February 2014, Smith & Nephew announced the purchase of ArthroCare for US$1.7 billion in cash. This was seen as a move to broaden the company's sports medicine range for minimally invasive surgery moves the company into the Ear, Nose & Throat market.[21]

In October 2015 Smith & Nephew announced the acquisition of Blue Belt Technologies (led by Eric Timko) for USD $275 million, securing a leading position in the fast-growing area of orthopaedic robotics-assisted surgery.[22]

In March 2019 Smith & Nephew announced the acquisition of orthopedic joint reconstruction business unit of Brainlab to further its foray into robotic surgery.[23]

In June 2019 Smith & Nephew acquired Atracsys Sàrl, the Switzerland-based provider of optical tracking technology used in computer-assisted surgery.[24]

In October 2019, Smith & Nephew announced Nawana would stand down "because his requests for higher pay, in line with the packages awarded by US medical device-makers, could not be met under UK corporate governance standards". He is replaced by Roland Diggelman.[25]

Operations
The Smith and Nephew factory in Kingston upon Hull, United Kingdom

Smith & Nephew operates in three market segments through separate global business units under the Smith & Nephew brand name:[26]

Controversies

In February 2012 Smith & Nephew plc agreed to pay US$22.2 million to settle multiple US Foreign Corrupt Practices Act (FCPA) offenses committed by its US and German subsidiaries.[27] Under the new agreements Smith & Nephew PLC paid $5.4 million in restitution and interest to settle the SEC's civil charges. Its US subsidiary Smith & Nephew Inc. paid a $16.8 million criminal fine.[28] The company admitted to having bribed government-employed doctors in Greece to use its medical equipment over the past decade.[29] The company entered into a deferred prosecution agreement with the US Department of Justice (DOJ) and agreed to retain a compliance monitor for 18 months.[30]

Awards

Awards include:

  • Manufacturer of the Year in 2007[31]
  • Smith & Nephew Advanced Wound Management won Logistics and Supply Chain Manufacturer Award 2006[32]
  • ASM International 2005 Engineering Materials Achievement Award for Smith & Nephew's trademarked oxinium technology[33]
  • Smith & Nephew's Back Pain Study Receives Outstanding Paper Award at North American Spine Society 2003 Annual Meeting[34]

References
  1. Winter, Phil (11 January 2019). "Smith & Nephew's unlikely past from pharmacy to global giant". hulldailymail. Retrieved 10 June 2020.
  2. Kollewe, Julia (21 October 2019). "Smith & Nephew chief executive to stand down after pay row". The Guardian. ISSN 0261-3077. Retrieved 10 June 2020.
  3. Media, Insider. "Plans in for major Smith & Nephew works". Insider Media Ltd. Retrieved 10 June 2020.
  4. Winter, Phil (11 January 2019). "Smith & Nephew's unlikely past from pharmacy to global giant". hulldailymail. Retrieved 10 June 2020.
  5. Kollewe, Julia (21 October 2019). "Smith & Nephew chief executive to stand down after pay row". The Guardian. ISSN 0261-3077. Retrieved 10 June 2020.
  6. Media, Insider. "Plans in for major Smith & Nephew works". Insider Media Ltd. Retrieved 10 June 2020.
  7. "Annual Results 2019" (PDF). Smith & Nephew plc. Retrieved 28 February 2020.
  8. "About us". Smith & Nephew. Retrieved 10 March 2019.
  9. "SNN Profile | Smith & Nephew SNATS, Inc. Comm Stock - Yahoo! Finance". finance.yahoo.com. Retrieved 5 September 2012.
  10. Winter, Phil (11 January 2019). "Smith & Nephew's unlikely past from pharmacy to global giant". hulldailymail. Retrieved 10 June 2020.
  11. Kollewe, Julia (21 October 2019). "Smith & Nephew chief executive to stand down after pay row". The Guardian. ISSN 0261-3077. Retrieved 10 June 2020.
  12. Media, Insider. "Plans in for major Smith & Nephew works". Insider Media Ltd. Retrieved 10 June 2020.
  13. "Smith & Nephew History". Global.smith-nephew.com. Retrieved 2 April 2013.
  14. "Watson-Marlow profile". Watson-marlow.se. Retrieved 18 April 2011.
  15. "Smith & Nephew to buy Oratec for $310mm in cash". Windhover Information. February 2002. Archived from the original on 18 July 2011. Retrieved 8 March 2009.
  16. "Smith & Nephew buys UK hip resurfacing business". Biomedical Materials. 1 May 2004. Archived from the original on 23 October 2012. Retrieved 8 March 2009 – via Highbeam.
  17. "Smith & Nephew buys Swiss company Plus Orthopedics". Biomedical Materials. 1 April 2007. Archived from the original on 23 October 2012. Retrieved 8 March 2009 – via Highbeam.
  18. "Smith & Nephew buys wound care firm BlueSky for $110m". Independent. 12 May 2007. Retrieved 8 March 2009.
  19. "Biomet stays part of informal SEC probe". Reuters. 11 October 2007. Retrieved 2 August 2008.
  20. "Smith & Nephew to Buy Healthpoint for $782 Million". Bloomberg. 28 November 2012. Retrieved 18 March 2013.
  21. "Smith & Nephew to Buy ArthroCare for $1.7 Billion in Cash". Bloomberg. 3 February 2014. Retrieved 27 March 2014.
  22. "Smith & Nephew makes strategic investment in surgical robotics with acquisition of Blue Belt Technologies | Smith & Nephew". www.smith-nephew.com. Retrieved 11 September 2019.
  23. "Smith & Nephew Acquires Brainlab Orthopaedic Joint Reconstruction Business". Brainlab. Retrieved 11 September 2019.
  24. "Smith & Nephew expands digital surgery ecosystem with acquisition of innovator in optical tracking technology". OrthoFeed. 12 June 2019. Retrieved 11 September 2019.
  25. Kollewe, Julia. "Smith & Nephew chief executive to stand down after pay row". The Guardian. Retrieved 28 October 2019.
  26. "Smith & Nephew". The Telegraph. Retrieved 12 April 2017.
  27. The FCPA Blog (6 February 2012). "Smith & Nephew Reaches $22 Million Settlement". The FCPA Blog. Retrieved 10 April 2012.
  28. "Smith & Nephew to pay $22.2M in US settlements". 6 February 2012. Retrieved 17 June 2013.
  29. Andrew Jack (6 February 2012). "Smith & Nephew in $22m bribes fine". The Financial Times. Retrieved 10 April 2012.
  30. Office of Public Affairs (6 February 2012). "Medical Device Company Smith & Nephew Resolves Foreign Corrupt Practices Act Investigation". The United States Department of Justice. Retrieved 10 April 2012.
  31. "Smith & Nephew wins manufacturing award". On Target. 2007. Archived from the original on 5 February 2008. Retrieved 2 August 2008.
  32. "Oliver Wright". Archived from the original on 6 January 2009. Retrieved 7 October 2010.
  33. "Smith & Nephew wins award for oxinium technology". Bimedical Materials. 1 November 2005. Archived from the original on 4 November 2012. Retrieved 7 October 2010.
  34. "North American Spine Society 2003 Annual Meeting" (Press release). Smith & Nephew. Archived from the original on 2 December 2013. Retrieved 2 April 2013.

Books
  1. J Foreman-Peck, Smith & Nephew in the Health Care Industry, Edward Elgar 1995
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.